August 5, 2020

MADRC Staff Present at Alzheimer's Association International Conference

The virtual Alzheimer’s Association International Conference (AAIC) last week brought together thousands of researchers from across the globe to share their findings. We are proud of the many MADRC-affiliated staff who presented study results and theories that will help advance Alzheimer’s and related dementia research!
Attached is a list of presentations made by MADRC team members* at AAIC (*in red).


August 5, 2020

Dr. Brad Dickerson Named Professor of Neurology at Harvard Medical School

Congratulations to Dr. Brad Dickerson who was recently promoted to Professor of Neurology at Harvard Medical School! Dr. Dickerson is the MGH Tommy Rickles Endowed Chair in Primary Progressive Aphasia Research, Director of the Frontotemporal Disorders Unit, and Leader of the Alzheimer Center Imaging Core. He has been an NIH-funded investigator continuously for more than 17 years and has over 195 peer-reviewed publications.

To learn more about Dr. Dickerson’s work:

July 28, 2020

Dr. Yakeel Quiroz Receives Inge-Grundke-Iqbal Award

Dr. Yakeel T. Quiroz received the Inge-Grundke-Iqbal Award for Alzheimer’s Research at the Alzheimer's Association International Conference underway this week! This award is presented to the senior author of the most impactful study published in Alzheimer’s research during the two calendar years preceding AAIC.

Dr. Quiroz is an Associate Professor in the Departments of Psychiatry and Neurology at Massachusetts General Hospital, Harvard Medical School, Director of the MGH Familial Dementia Neuroimaging Lab, and Director of the Multicultural Alzheimer’s Prevention Program (MAPP). She received the award for her investigation into the role of APOE3 Christchurch (R136S) mutation in the resistance to autosomal dominant Alzheimer’s disease. Her research group recently identified a PSEN1 mutation carrier who did not develop mild cognitive impairment until three decades after the expected age of onset. Additionally, this individual was found to carry two copies of the APOE3 Christchurch mutation, and had unusually high brain amyloid levels and limited tau and neurodegenerative measurements.

Dr. Quiroz’s findings, “Resistance to autosomal dominant Alzheimer’s disease in an APOE3 Christchurch homozygote: a case report,” were published in Nature Medicine in 2019, and provide important insights into the role of this APOE mutation in neurodegeneration and clinical onset of Alzheimer’s disease dementia.

June 10, 2020

Celebrate Memory Sunday - June 14th

It’s Alzheimer’s and Brain Awareness Month and on June 14th we will be celebrating Memory Sunday across New England! This annual event raises awareness about Alzheimer’s disease and its impact on African American communities.

On Memory Sunday, African American congregations utilize the pulpit to raise awareness of Alzheimer’s and dementia, risk reduction, the importance of early diagnosis and caregiver support.

MADRC is collaborating with multiple organizations to produce, and provide resources for, this important event. For more information visit:

Memory Sunday is an initiative of The National Brain Health Center for African-Americans, a program of The Balm In Gilead.


June 9, 2020

Virtual Aging & Memory Loss Road Map Education Series

Spread the word! MADRC is excited to announce that we are bringing our Aging & Memory Loss Road Map Education Series online! Launched in 2019, The Road Map Series is designed to support patients and families concerned with memory and thinking issues. Each session will explore a different topic and provide valuable tools and resources for attendees. This online series is co-sponsored by the Global Alzheimer's Platform Foundation. 

Registration is now open via Eventbrite here:

Registrants will receive a link for the online presentation approximately two days prior to each event. For more information contact Nancy Coppelman:



June 1, 2020

Statement on Racial Injustice

The staff of the Massachusetts Alzheimer’s Disease Research Center (MADRC), the Harvard Aging Brain Study, and the Center for Alzheimer Research and Treatment are fully committed to racial and social justice. We value ALL people and strive every day to help bridge the gap of inequity in healthcare and research.

MADRC’s work is informed by collaboration with a number of organizations that focus on serving specific communities such as African Americans and Latinos. We value our discussions with the leaders of these groups as they provide valuable perspectives to incorporate into our community outreach and education programs.

The horrific, violent crimes in Minnesota, Georgia and elsewhere recently against Black people, including George Floyd, Ahmaud Arbery and Breonna Taylor, underscore the fact that there is much more work to be done to combat racism and inequity across the country and here in our own community. We continue to stand with the members of the Black community as we work toward change and combat hatred.